Lunai Bioworks (LNAI) Receivables - Other (2011 - 2025)

Lunai Bioworks (LNAI) posted quarterly Receivables - Other of $127080.0 for Q1 2025, little changed quarter-over-quarter from $127080.0 in Q4 2024.

Lunai Bioworks (LNAI) Receivables - Other (2011 - 2025) Analysis & Trends

Lunai Bioworks' Receivables - Other history runs 13 years deep, the most recent figure standing at $127080.0 for Q1 2025.

In Q1 2025, Receivables - Other changed N/A year-over-year to $127080.0; the TTM figure through Mar 2025 stood at $127080.0 (changed N/A YoY), while the FY2024 annual figure was $1.1 million, changed N/A from the prior year.
Receivables - Other for Q1 2025 stood at $127080.0, roughly flat from $127080.0 in the prior quarter.
The five-year high for Receivables - Other was $1.2 million in Q3 2024, with the low at $1640.0 in Q2 2021.
The 3-year median for Receivables - Other is $127080.0 (2024), against an average of $521281.4.
Peak annual rise in Receivables - Other reached 17.26% in 2021, while the deepest fall reached 17.26% in 2021.
Lunai Bioworks' Receivables - Other stood at $1640.0 in 2021, then surged by 7648.78% to $127080.0 in 2024, then changed by 0.0% to $127080.0 in 2025.
Business Quant data shows LNAI's Receivables - Other at $127080.0 in Q1 2025, $127080.0 in Q4 2024, and $1.2 million in Q3 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn
10	Lunai Bioworks	6.87 Mn	3.72 Mn	20,942.00

Download Data